News Industry News New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre October 23, 2012
News Industry News Titanium-Nitride-Oxide Bio Active Technology in ACS Patients: Present and Future May 18, 2011
News Industry News A Prospective, Randomised and Multicentre Trial Comparing Titan2 Bio Active Stent (BAS) and Xience V Drug Eluting Stent (DES): The BASE-ACS Trial May 17, 2011